21,621
Views
114
CrossRef citations to date
0
Altmetric
Review

Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy

, ORCID Icon, , , ORCID Icon, & show all

References

  • Bantz SK, Zhu Z, Zheng T. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. J Clin Cell Immunol. 2014 Apr;5(2):202.
  • Genuneit JJ, Seibold AM, Apfelbacher CJ. Overview of systematic reviews in allergy epidemiology. Allergy. 2017 Jun;72(6):849–856.
  • Spergel Jonathan MJM. Atopic dermatitis and the atopic march. J Allergy Clin Immunol. 2003 Dec;112(6):118–127.
  • Spergel Jonathan MJM. Atopic march: link to upper airways. Curr Opin Allergy Clin Immunol. 2005 Feb;5(1):17–21.
  • Ker Jennifer J, Hartert TV. The atopic march: what’s the evidence? Ann Allergy, Asthma Immunol. 2009;103(4):282–289.
  • Oliveira Clara C. More than skin deep: the systemic nature of atopic dermatitis. Eur J Dermatol. 2019 May 23; 29(3):250–258.
  • Paller Amy SAS. The atopic march and atopic multimorbidity: many trajectories, many pathways. J Allergy Clin Immunol. 2019 Jan;143(1):46–55.
  • Tran Maxwell MMM. Predicting the atopic march: results from the canadian healthy infant longitudinal development study. J Allergy Clin Immunol. 2018;141(2):601–607.
  • Davidson WF. Report from the national institute of allergy and infectious diseases workshop on “atopic dermatitis and the atopic march: mechanisms and interventions”. J Allergy Clin Immunol. 2019 Mar;143(3):894–913.
  • Celakovska J, Ettler K, Ettlerova K, et al. Food hypersensitivity in patients over 14 years of age suffering from atopic dermatitis. Indian J Dermatol. 2014;59(3):316.
  • Lenaeus JMJ, Hirschmann J. Primary care of the patient with asthma. Med Clin North Am. 2015 Nov;99(5):953–967.
  • Nutten Sophie S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66:8–16.
  • Illi S, von Mutius E, Lau S, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol. 2004;113(5):925–931.
  • Belgrave DC, Granell R, Simpson A, et al. Developmental profiles of eczema, wheeze, and rhinitis: two population-based birth cohort studies. PLoS Med. 2014;11(10):e1001748.
  • Kuruvilla ME, Lee FE, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol. 2019;56(2):219–233.
  • Leomicronn B. T cells in allergic asthma: key players beyond the Th2 pathway. Curr Allergy Asthma Rep. 2017;17(7): 43.
  • Eifan AO, Durham SR. Pathogenesis of rhinitis. Clin Exp Allergy. 2016;46(9):1139–1151.
  • Bosnjak B, Stelzmueller B, Erb KJ, et al. Treatment of allergic asthma: modulation of Th2 cells and their responses. Respir Res. 2011;12:114.
  • Wu TD, Brigham EP, McCormack MC. Asthma in the primary care setting. Med Clin North Am. 2019 May;103(3):435–452.
  • Pols DH, Wartna JB, Moed H. Atopic dermatitis, asthma and allergic rhinitis in general practice and the open population: A systematic review. Scand J Prim Health Care. 2016 Jun;34(2):143–150.
  • Massoth Landon L. Asthma and chronic rhinosinusitis: diagnosis and medical management. Med Sci. 2019 Mar 27;7(4):53.
  • Bauchau V. Prevalence and rate of diagnosis of allergic rhinitis in europe. Eur Respir J. 2004 Nov;24(5):758–764.
  • Smith S. Atopic dermatitis in adults: an australian management consensus. Australas J Dermatol. 2020;61(1):23–32.
  • Feldman SR. The challenge of managing atopic dermatitis in the united states. Am Health Drug Benefits 2019 Apr;12(2):83–93.
  • Lee JH, Son SW, Cho SH. A comprehensive review of the treatment of atopic eczema. Allergy Asthma Immunol Res. 2016 May;8(3):181–190.
  • Theodosiou Grigorios G. Burden of atopic dermatitis in swedish adults: A population-based study. Acta Derm Venereol. 2019 Oct; 99(11):964–970.
  • Ding BB, Small M. Disease burden of mild asthma: findings from a cross-sectional real-world survey. Adv Ther. 2017;34(5):1109–1127.
  • Zuberbier T, Lötvall J, Simoens S, et al. Economic burden of inadequate management of allergic diseases in the european union: A GA2LEN review. Allergy. 2014;69(10):1275–1279.
  • Loftus PA, Wise SK. Epidemiology and economic burden of asthma. Int Forum Allergy Rhinology. 2015;5:S7–S10.
  • Wang Y, Ghoshal AG, Bin Abdul Muttalif AR. Quality of life and economic burden of respiratory disease in asia-pacific-asia-pacific burden of respiratory diseases study. Value Health Reg Issues. 2016 May;9:72–77.
  • Sullivan PW, Ghushchyan VH, Slejko JF. The burden of adult asthma in the united states: evidence from the medical expenditure panel survey. J Allergy Clin Immunol. 2011 Feb;127(2):363–369.
  • Uphoff Eleonora E, Cabieses B, Pinart M. A systematic review of socioeconomic position in relation to asthma and allergic diseases. Eur Respir J. 2015 Oct;46(2):364–374.
  • Linneberg A. Burden of allergic respiratory disease: A systematic review. Clin Mol Allergy. 2016; 14:12.
  • Nørreslet LB, Ebbehøj NE, Ellekilde Bonde JP. The impact of atopic dermatitis on work life - a systematic review. J Eur Acad Dermatol Venereol. 2018 Jan;32(1):23–38.
  • Gutknecht Mandy M, Reinert R, Augustin M. Review of health economic analyses in atopic dermatitis: how diverse is the literature? Expert Rev Pharmacoecon Outcomes Res. 2019;19(2):127–145.
  • Ballardini N, Kull I, Lind T, et al. Development and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohort. Allergy. 2012;67(4):537–544.
  • Gough H, Grabenhenrich L, Reich A, et al. Allergic multimorbidity of asthma, rhinitis and eczema over 20 years in the german birth cohort MAS. Pediatr Allergy Immunol. 2015;26(5):431–437.
  • Lundbäck BB, Backman H, Lötvall J. Is asthma prevalence still increasing? Expert Rev Respir Med. 2016;10(1):39–51.
  • Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006 Nov 23;355(21):2226–2235.
  • Sears MR. Trends in the prevalence of asthma. Chest. 2014 Feb;145(2):219–225.
  • European Lung White book. Sheffield, United Kingdom: ERS Publications Office; 2013.
  • Morgan BW. Asthma and allergic disorders in uganda: A population-based study across urban and rural settings. J allergy clin immunol. 2018 Sep–Oct;6(5):1580–1587.
  • Pearce Neil N, Ait-Khaled N, Beasley R. Worldwide trends in the prevalence of asthma symptoms: phase III of the international study of asthma and allergies in childhood (ISAAC). Thorax. 2007 Nov;62(9):758–766.
  • [cited 2020 Sep 8]. https://www.erswhitebook.org/chapters/adult-asthma/.
  • Masoli M, Fabian D, Holt S. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy. 2004 May;59(5):469–478.
  • GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the global burden of disease study 2013. Lancet. 2015 Jan 10;385(9963):117–171.
  • GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: A systematic analysis for the global burden of disease study 2016. Lancet. 2017 Nov 16;390(10100):1151–1210.
  • GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the global burden of disease study 2015. Lancet. 2016 Oct 08;388(10053):1459–1544.
  • Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma. 1990–2015: A systematic analysis for the global burden of disease study 2015. Lancet Respir Med. 2017;5(9):691–706.
  • Ernst R. Indirect costs and cost-effectiveness analysis. Value Health. 2006 Jul-Aug;9(4):253–261.
  • Bahadori K. Economic burden of asthma: A systematic review. BMC Pulm Med. 2009 May 19;9:24.
  • Nunes C. Asthma costs and social impact. Asthma Res Pract. 2017;3:1.
  • Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the united states, 2008–2013. Ann Am Thorac Soc. 2018;15(3):348–356.
  • Mukherjee M, Stoddart A, Gupta RP. The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases. BMC Med. 2016 29;14(1). DOI:10.1186/s12916-016-0657-8
  • Ehteshami-Afshar SS, FitzGerald JM, Doyle-Waters MM. The global economic burden of asthma and chronic obstructive pulmonary disease. The International Journal of Tuberculosis and Lung Disease. 2016 Jan;20(1):11–23.
  • Springett VH. Hospital admission and absence from work attributed to asthma. Br Med J. 1969;1(5641):402–403.
  • Birnbaum HG, Berger WE, Greenberg PE, et al. Direct and indirect costs of asthma to an employer. J Allergy Clin Immunol. 2002;109(2):264–270.
  • Cisternas MG, Blanc PD, Yen IH, et al. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol. 2003;111(6):1212–1218.
  • Szucs TD, Anderhub H, Rutishauser M. The economic burden of asthma: direct and indirect costs in switzerland. Eur Respir J. 1999;13(2):281–286.
  • Kim JL, Toren K, Lohman S, et al. Respiratory symptoms and respiratory-related absence from work among health care workers in sweden. J Asthma. 2013;50(2):174–179.
  • Kleinman NL, Brook RA, Ramachandran S. An employer perspective on annual employee and dependent costs for pediatric asthma. Ann Allergy Asthma Immunol. 2009;103(2):114–120.
  • van Boven JFM, van de Hei SJ, Sadatsafavi M. Making sense of cost-effectiveness analyses in respiratory medicine: A practical guide for non-health economists. Eur Respir J. 2019;53(3):1801816.
  • Rabe KF, Adachi M, Lai CK, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114(1):40–47.
  • Ehteshami-Afshar Solmaz S. The impact of comorbidities on productivity loss in asthma patients. Respir Res. 2016;17:1.
  • Dierick BJH, Flokstra-de Blok B, van der Molen T, et al. The impact of asthma and/or COPD on work absence. Eur Respir J. 2018;52(suppl 62):PA4216.
  • Lamb CE. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the united states from an employer perspective. Curr Med Res Opin. 2006 Jun;22(6):1203–1210.
  • Sadatsafavi M, Rousseau R, Chen W, et al. The preventable burden of productivity loss due to suboptimal asthma control: A population-based study. Chest. 2014;145(4):787–793.
  • Accordini Simone S. The cost of persistent asthma in europe: an international population-based study in adults. Int Arch Allergy Immunol. 2013;160(1):93–101.
  • Arpinelli F. Health-related quality of life measurement in asthma and chronic obstructive pulmonary disease: review of the 2009-2014 literature. Multidiscip Respir Med. 2016;11:5.
  • Hossny Elham E. Severe asthma and quality of life. World Allergy Organ J. 2017;10:1.
  • Hooi LN. What are the clinical factors that affect quality of life in adult asthmatics? Med J Malaysia. 2003 Oct;58(4):506–515.
  • Bae YJ. Reliability and validity of the st george’s respiratory questionnaire for asthma. Int J Tuberc Lung Dis. 2011 Sep;15(7):966–971.
  • Uchmanowicz Bartosz B. Clinical factors affecting quality of life of patients with asthma. Patient Prefer Adherence. 2016;10:579–589.
  • Ebmeier S, Thayabaran D, Braithwaite I, et al. Trends in international asthma mortality: analysis of data from the WHO mortality database from 46 countries (1993-2012). Lancet. 2017;390(10098):935–945.
  • Burney PP. The global burden of chronic respiratory disease in adults. Int J Tuberc Lung Dis. 2015 Jan;19(1):10–20.
  • Wallace DV. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008 Oct;122(2):1–84.
  • Tan Rachel R. Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: A global phenomenon. Asthma Res Pract. 2017;3:8.
  • Aït-Khaled NN. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: the international study of asthma and allergies in childhood (ISAAC) phase three. Allergy. 2009 Jan;64(1):123–148.
  • Bousquet J. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the world health organization, GA(2)LEN and AllerGen). Allergy. 2008 Apr;63:8–160.
  • Reed Shelby DSD. The economic burden of allergic rhinitis: A critical evaluation of the literature. Pharmacoeconomics. 2004;22(6):345–361.
  • Ray NF. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses. J Allergy Clin Immunol. 1999 Mar;103(3):401–407.
  • Law AW. Direct costs of allergic rhinitis in the united states: estimates from the 1996 medical expenditure panel survey. J Allergy Clin Immunol. 2003 Feb;111(2):296–300.
  • Cardell LO. TOTALL: high cost of allergic rhinitis-a national swedish population-based questionnaire study. NPJ Prim Care Respir Med. 2016 Feb-Apr;26:15082.
  • Colás C. Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN study. Allergy. 2017 Jun;72(6):959–966.
  • Belhassen M. Costs of perennial allergic rhinitis and allergic asthma increase with severity and poor disease control. Allergy. 2017 Jun;72(6):948–958.
  • Celik Gülfem G. Direct cost assessments in subjects with seasonal allergic rhinitis living in ankara, turkey. Allergy Asthma Proc. 2004 Mar-Apr;25(2):107–113.
  • Kim SY. Economic burden of allergic rhinitis in korea. Am J Rhinology Allergy 2010 Sep–Oct;24(5):110–113.
  • Ghoshal AG. The burden of segregated respiratory diseases in india and the quality of care in these patients: results from the asia-pacific burden of respiratory diseases study. Lung India. 2016 Nov-Dec;33(6):611–619.
  • Crystal-Peters J. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care. 2000 Mar;6(3):373–378.
  • van der Leeuw S, van der Molen T, Dekhuijzen PN, et al. The minimal clinically important difference of the control of allergic rhinitis and asthma test (CARAT): cross-cultural validation and relation with pollen counts. NPJ Prim Care Respir Med. 2015;25:14107.
  • Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol. 2001 Sep;108(1):45–53.
  • Meltzer EO. Allergic rhinitis: burden of illness, quality of life, comorbidities, and control. Immunol Allergy Clin North Am. 2016 May;36(2):235–248.
  • Celakovska J, Bukac J. The severity of atopic dermatitis evaluated with the SCORAD index and the occurrence of bronchial asthma and rhinitis, and the duration of atopic dermatitis. Allergy Rhinol (Providence). 2016;7(1):8–13.
  • Wallach Daniel D. Atopic dermatitis/atopic eczema. Chem Immunol Allergy. 2014;100:81–96.
  • Weidinger S. Atopic dermatitis. Lancet. 2016 Mar 12;387(10023):1109–1122.
  • Asher MI. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet. 2006 Aug 26;368(9537):733–743.
  • Odhiambo Joseph AJA. Global variations in prevalence of eczema symptoms in children from ISAAC phase three. J Allergy Clin Immunol. 2009 Dec;124(6):1251–1258.
  • Yong M-YA. Atopic dermatitis: racial and ethnic differences. Dermatol Clin. 2017 Jul;35(3):395–402.
  • Yu JS. Prevalence of atopic dermatitis in korea: analysis by using national statistics. J Korean Med Sci. 2012 Jun;27(6):681–685.
  • Al-Afif KAM, Buraik MA, Buddenkotte J. Understanding the burden of atopic dermatitis in africa and the middle east. Dermatol Ther (Heidelb). 2019 Jun;9(2):223–241.
  • Barbarot S, Auziere S, Gadkari A, et al., Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73(6): 1284–1293.
  • Silverberg JI. Health care utilization, patient costs, and access to care in US adults with eczema: A population-based study. JAMA Dermatol. 2015 Jul;151(7):743–752.
  • Silverberg JI, Gelfand JM, Margolis DJ, et al. Atopic dermatitis in US adults: from population to health care utilization. J Allergy Clin Immunol Pract. 2019;7(5):1524–1532.e2.
  • Chiesa Fuxench ZC, Block JK, Boguniewicz M, et al. Atopic dermatitis in america study: A cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population. J Invest Dermatol. 2019;139(3):583–590.
  • Drucker Aaron MAM, Wang AR, Li W-Q. The burden of atopic dermatitis: summary of a report for the national eczema association. J Invest Dermatol. 2017;137(1):26–30.
  • Bickers DR, Lim HW, Margolis D. The burden of skin diseases: 2004 a joint project of the american academy of dermatology association and the society for investigative dermatology. J Am Acad Dermatol. 2006 Nov;55(3):490–500.
  • Lim HW, Collins SAB, Resneck JS Jr, et al. The burden of skin disease in the united states. J Am Acad Dermatol. 2017;76(5):958–972.e2.
  • Lim HW, Collins SAB, Resneck JS Jr, et al. A risk adjustment approach to estimating the burden of skin disease in the united states. J Am Acad Dermatol. 2018;78(1):129–140.
  • Zink AGS, Arents B, Fink-Wagner A. Out-of-pocket costs for individuals with atopic eczema: A cross-sectional study in nine european countries. Acta Derm Venereol. 2019 Mar 01;99(3):263–267.
  • van Os-medendorp H, Appelman-Noordermeer S, Bruijnzeel-Koomen C, et al. Sick leave and factors influencing sick leave in adult patients with atopic dermatitis: A cross-sectional study. J Clin Med. 2015;4(4):535–547.
  • Kim C, Park KY, Ahn S. Economic impact of atopic dermatitis in korean patients. Ann Dermatol. 2015 Jun;27(3):298–305.
  • Zuberbier T, Orlow SJ, Paller AS. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol. 2006 Jul;118(1):226–232.
  • Arima K, Gupta S, Gadkari A. Burden of atopic dermatitis in japanese adults: analysis of data from the 2013 national health and wellness survey. The Journal of Dermatology. 2018 Apr;45(4):390–396.
  • Drucker AM. Atopic dermatitis: burden of illness, quality of life, and associated complications. Allergy Asthma Proc. 2017 Jan 01;38(1):3–8.
  • Abolfotouh MA. Quality of life in patients with skin diseases in central saudi arabia. Int J Gen Med. 2012;5:633–642.
  • Weisshaar EE. Pruritus as a leading symptom: clinical characteristics and quality of life in german and ugandan patients. Br J Dermatol. 2006 Nov;155(5):957–964.
  • Tsai TF. Burden of atopic dermatitis in asia. J Dermatol. 2019 Aug 22;46(10):825–834.
  • Hay RJ, Johns NE, Williams HC. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014 Jun;134(6):1527–1534.
  • Allen KJ, Dharmage SC. The role of food allergy in the atopic march. Clin Exp Allergy. 2010;40(10):1439–1441.
  • Emons JAM, Gerth van Wijk R. Gerth van Wijk R. Food allergy and asthma: is there a link? Curr Treat Options Allergy. 2018;5(4):436–444.
  • Scadding GK, Scadding GW. Diagnosing allergic rhinitis. Immunol Allergy Clin North Am. 2016;36(2):249–260.
  • Tham EH. Mechanisms by which atopic dermatitis predisposes to food allergy and the atopic march. Allergy Asthma Immunol Res. 2019 Jan;11(1):4–15.
  • Saidova A, Hershkop AM, Ponce M, et al. Allergen-specific T cells in IgE-mediated food allergy. Arch Immunol Ther Exp (Warsz). 2018;66(3):161–170.
  • Turnbull JL, Adams HN, Gorard DA. Review article: the diagnosis and management of food allergy and food intolerances. Aliment Pharmacol Ther. 2015;41(1):3–25.
  • Zuidmeer L, Goldhahn K, Rona RJ, et al., The prevalence of plant food allergies: A systematic review. J Allergy Clin Immunol. 2008;121(5): 1210–1218.e4.
  • Xepapadaki P, Fiocchi A, Grabenhenrich L, et al. Incidence and natural history of hen’s egg allergy in the first 2 years of life-the EuroPrevall birth cohort study. Allergy. 2016;71(3):350–357.
  • Schoemaker AA, Sprikkelman AB, Grimshaw KE, et al. Incidence and natural history of challenge-proven cow’s milk allergy in european children–EuroPrevall birth cohort. Allergy. 2015;70(8):963–972.
  • Koplin JJ, Mills EN, Allen KJ. Epidemiology of food allergy and food-induced anaphylaxis: is there really a western world epidemic? Curr Opin Allergy Clin Immunol. 2015;15(5):409–416.
  • Kummeling I, Mills EN, Clausen M, et al. The EuroPrevall surveys on the prevalence of food allergies in children and adults: background and study methodology. Allergy. 2009;64(10):1493–1497.
  • Lyons SA, Burney PGJ, Ballmer-Weber BK, et al., Food allergy in adults: substantial variation in prevalence and causative foods across europe. J Allergy Clin Immunol Pract. 2019;7(6): 1920–1928.e11.
  • Mahesh PA, Fedorova O, Leung TF, et al. Prevalence of food sensitization and probable food allergy among adults in india: the EuroPrevall INCO study. Allergy. 2016;71(7):1010–1019.
  • Nwaru BI, Hickstein L, Panesar SS, et al., The epidemiology of food allergy in europe: A systematic review and meta-analysis. Allergy. 2014;69(1): 62–75.
  • Loh Wenyin W. The epidemiology of food allergy in the global context. Int J Environ Res Public Health. 2018;15(9):2043.
  • Wang XY, Zhuang Y, Ma TT, et al. Prevalence of self-reported food allergy in six regions of inner mongolia, northern china: A population-based survey. Med Sci Monit. 2018;24(24):1902–1911.
  • Sicherer SH, Sampson HA. Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. J Allergy Clin Immunol. 2018;141(1):41–58.
  • Verrill Linda L, Bruns R, Luccioli S. Prevalence of self-reported food allergy in U.S. adults: 2001, 2006, and 2010. Allergy Asthma Proc. 2015 Nov-Dec;36(6):458–467.
  • Rona RJ, Keil T, Summers C, et al. The prevalence of food allergy: A meta-analysis. J Allergy Clin Immunol. 2007;120(3):638–646.
  • Jansson SA, Protudjer JL, Arnlind Heibert M, et al., Socioeconomic evaluation of well-characterized allergy to staple foods in adults. Allergy. 2014;69(9): 1241–1247.
  • Fox M, Mugford M, Voordouw J, et al. Health sector costs of self-reported food allergy in europe: A patient-based cost of illness study. Eur J Public Health. 2013;23(5):757–762.
  • Patel DA, Holdford DA, Edwards E, et al. Estimating the economic burden of food-induced allergic reactions and anaphylaxis in the united states. J Allergy Clin Immunol. 2011;128(1):110–115.e5.
  • Bilaver LA, Chadha AS, Doshi P. Economic burden of food allergy: A systematic review. Ann Allergy Asthma Immunol. 2019 Apr;122(4):373–380.
  • Flokstra-de Blok BM, DunnGalvin A, Vlieg-Boerstra BJ, et al. Development and validation of the self-administered food allergy quality of life questionnaire for adolescents. J Allergy Clin Immunol. 2008;122(1):139–44, 144.e1-2.
  • Flokstra-de Blok BM, DunnGalvin A, Vlieg-Boerstra BJ, et al. Development and validation of a self-administered food allergy quality of life questionnaire for children. Clin Exp Allergy. 2009;39(1):127–137.
  • DunnGalvin A, de BlokFlokstra BM, Burks AW, et al. Food allergy QoL questionnaire for children aged 0-12 years: content, construct, and cross-cultural validity. Clin Exp Allergy. 2008;38(6):977–986.
  • Cohen BL, Noone S, Munoz-Furlong A, et al. Development of a questionnaire to measure quality of life in families with a child with food allergy. J Allergy Clin Immunol. 2004;114(5):1159–1163.
  • Greenhawt M. Food allergy quality of life and living with food allergy. Curr Opin Allergy Clin Immunol. 2016;16(3):284–290.
  • DunnGalvin Audrey A. The effects of food allergy on quality of life. Chem Immunol Allergy. 2015;101:235–252.
  • Kansen HM, Le TM, Meijer Y, et al. The impact of oral food challenges for food allergy on quality of life: A systematic review. Pediatr Allergy Immunol. 2018;29(5):527–537.
  • Kulthanan K. Economic burden of the inadequate management of allergic rhinitis and urticaria in asian countries based on the GA2LEN model. Allergy Asthma Immunol Res. 2018 Jul;10(4):370–378.
  • Drucker AM, Wang AR, Qureshi AA. Research gaps in quality of life and economic burden of atopic dermatitis: the national eczema association burden of disease audit. JAMA Dermatol. 2016 Jan;152(8):873–874.
  • Yii AC, Tay TR, Choo XN, et al. Precision medicine in united airways disease: A “treatable traits” approach. Allergy. 2018;73(10):1964–1978.
  • Milner JD. Primary atopic disorders. Annu Rev Immunol. 2020;38:785–808.
  • Pinart M, Benet M, Annesi-Maesano I, et al. Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: A population-based cohort study. Lancet Respir Med. 2014;2(2):131–140.
  • Akar-Ghibril N, Casale T, Custovic A, et al. Allergic endotypes and phenotypes of asthma. J Allergy Clin Immunol Pract. 2020;8(2):429–440.
  • Akinbami LJ, Sullivan SD, Campbell JD, et al. Asthma outcomes: healthcare utilization and costs. J Allergy Clin Immunol. 2012;129(3 Suppl):S49–64.
  • Kim CH, Dilokthornsakul P, Campbell JD, et al. Asthma cost-effectiveness analyses: are we using the recommended outcomes in estimating value? J Allergy Clin Immunol. 2018 Mar–Apr;6(2):619–632.